Results 341 to 350 of about 3,688,101 (379)
Some of the next articles are maybe not open access.
2002
The use of targeted therapies to treat infectious diseases is a novel application that requires a persistent infection that cannot be cleared by other means and the expression of microbial antigens on the surface of productively-infected cells. Although some bacterial or parasitic infections may meet these criteria, chronic viral infections and microbe-
Seth H. Pincus +2 more
openaire +1 more source
The use of targeted therapies to treat infectious diseases is a novel application that requires a persistent infection that cannot be cleared by other means and the expression of microbial antigens on the surface of productively-infected cells. Although some bacterial or parasitic infections may meet these criteria, chronic viral infections and microbe-
Seth H. Pincus +2 more
openaire +1 more source
1995
(Uploaded by Plazi from the Biodiversity Heritage Library) No abstract provided.
openaire +1 more source
(Uploaded by Plazi from the Biodiversity Heritage Library) No abstract provided.
openaire +1 more source
2008
Modern combination drug therapy has substantially improved the clinical management of HIV-1 infection. Still, the emergence of drug-resistant variants eventually leads to therapy failure in most patients. The selection of an optimal follow-up regimen is complicated by an ever-increasing range of possible drug combinations.
openaire +2 more sources
Modern combination drug therapy has substantially improved the clinical management of HIV-1 infection. Still, the emergence of drug-resistant variants eventually leads to therapy failure in most patients. The selection of an optimal follow-up regimen is complicated by an ever-increasing range of possible drug combinations.
openaire +2 more sources
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2007
There are, at present, 22 compounds which have been formally approved (by the US Food and Drug Administration) for the treatment of HIV infections (AIDS). According to their point of intervention with the HIV replicative cycle, these compounds can be classified in 5 categories: (1) NRTIs (nucleoside reverse transcriptase inhibitors): azidothymidine ...
openaire +1 more source
There are, at present, 22 compounds which have been formally approved (by the US Food and Drug Administration) for the treatment of HIV infections (AIDS). According to their point of intervention with the HIV replicative cycle, these compounds can be classified in 5 categories: (1) NRTIs (nucleoside reverse transcriptase inhibitors): azidothymidine ...
openaire +1 more source
La Revue du praticien, 1999
Anti-HIV drugs act by blocking intracellular replication of the virus by inhibiting viral enzyme either reverse transcriptase or protease. Reverse transcriptase inhibitors belong to 3 different categories: nucleoside analogues, which active forms are the triphosphorylated intracellular compound, non nucleoside inhibitors and the more recent nucleotide ...
openaire +1 more source
Anti-HIV drugs act by blocking intracellular replication of the virus by inhibiting viral enzyme either reverse transcriptase or protease. Reverse transcriptase inhibitors belong to 3 different categories: nucleoside analogues, which active forms are the triphosphorylated intracellular compound, non nucleoside inhibitors and the more recent nucleotide ...
openaire +1 more source
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.
Journal of Virological Methods, 1988R. Pauwels +7 more
semanticscholar +1 more source
Structure and Anti-HIV Activity of Betulinic Acid Analogues
Current Medical Science, 2018Qiu-xia Huang +5 more
semanticscholar +1 more source